424 related articles for article (PubMed ID: 33037986)
1. Applications of nanobodies in plant science and biotechnology.
Wang W; Yuan J; Jiang C
Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
[TBL] [Abstract][Full Text] [Related]
2. Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.
Wang Y; Fan Z; Shao L; Kong X; Hou X; Tian D; Sun Y; Xiao Y; Yu L
Int J Nanomedicine; 2016; 11():3287-303. PubMed ID: 27499623
[TBL] [Abstract][Full Text] [Related]
3. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
4. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
Ji F; Ren J; Vincke C; Jia L; Muyldermans S
Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
[TBL] [Abstract][Full Text] [Related]
5. Nanobodies: natural single-domain antibodies.
Muyldermans S
Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
[TBL] [Abstract][Full Text] [Related]
6. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
Front Immunol; 2018; 9():2553. PubMed ID: 30524421
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
[TBL] [Abstract][Full Text] [Related]
8. [Progress in nanobody and its application in diagnosis].
Kong Q; Yao Y; Chen R; Lu S
Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
[TBL] [Abstract][Full Text] [Related]
9. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
11. Applications of Nanobodies.
Muyldermans S
Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
[TBL] [Abstract][Full Text] [Related]
12. A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
[TBL] [Abstract][Full Text] [Related]
13. Development of Antibody and Nanobody Tools for P2X7.
Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies as probes to investigate purinergic signaling.
Eggers M; Rühl F; Haag F; Koch-Nolte F
Biochem Pharmacol; 2021 May; 187():114394. PubMed ID: 33388283
[TBL] [Abstract][Full Text] [Related]
15. Generation, expression and utilization of single-domain antibodies for in vivo protein localization and manipulation in sea urchin embryos.
Schrankel CS; Gökirmak T; Lee CW; Chang G; Hamdoun A
Methods Cell Biol; 2019; 151():353-376. PubMed ID: 30948018
[TBL] [Abstract][Full Text] [Related]
16. Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
Ditlev SB; Florea R; Nielsen MA; Theander TG; Magez S; Boeuf P; Salanti A
PLoS One; 2014; 9(1):e84981. PubMed ID: 24465459
[TBL] [Abstract][Full Text] [Related]
17. A Two-Step Approach for the Design and Generation of Nanobodies.
Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
[TBL] [Abstract][Full Text] [Related]
18. Structure of Nanobody Nb23.
Percipalle M; Hunashal Y; Steyaert J; Fogolari F; Esposito G
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207949
[TBL] [Abstract][Full Text] [Related]
19. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
Front Immunol; 2021; 12():838082. PubMed ID: 35116045
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of Camelid nanobodies in Nicotiana benthamiana.
Teh YH; Kavanagh TA
Transgenic Res; 2010 Aug; 19(4):575-86. PubMed ID: 19862637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
